Joseph Frucht‐Pery: Influence Statistics

Joseph Frucht‐Pery

Joseph Frucht‐Pery

Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel | Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel | ...

Joseph Frucht‐Pery: Expert Impact

Concepts for which Joseph Frucht‐Pery has direct influence: Ocular hypertension , Intraocular pressure , Proliferative activity , Rabbit eye , Visual acuity , Transscleral iontophoresis , Conjunctival fibroblasts .

Joseph Frucht‐Pery: KOL impact

Concepts related to the work of other authors for which for which Joseph Frucht‐Pery has influence: Ocular surface , Drug delivery , Conjunctival autograft , Topical mitomycin , Pterygium surgery , Nerve growth factor , Situ keratomileusis .

KOL Resume for Joseph Frucht‐Pery

Year
2018

Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

2016

Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel

2013

Hadassah University Hospital Department of Ophthalmology Jerusalem Israel

2011

Department of Ophthalmology, Hadassah University Hospital, 91120 Jerusalem, Israel

2008

Department of Ophthalmology, Hadassah, Hebrew University Medical Center, Jerusalem, Israel

2007

Director, The Retinoblastoma Centre, Childrens Hospital of Los Angeles, Los Angeles CA, USA

Professor of Ophthalmology, Ocular Oncology Service, The Royal Liverpool University Hospital, Liverpool, UK

Department of Ophthalmology, Hadassah Hebrew University Medical Center, Jerusalem, Israel

2006

Department of Ophthalmology, Hadassah University Hospital, The Hebrew University, Hadassah School of Medicine, Jerusalem, Israel

2005

Department of Ophthalmology, Hadassah University Hospital, Jerusalem 91120, Israel

2004

Department of Ophthalmology, Hadassah University Hospital, P.O. Box 12000, Jerusalem 91120, Israel

2003

Hadassah University Hospital, Jerusalem, Israel

2001

Department of Ophthalmology (Chowers, Anteby, Frucht-Pery), The Hebrew University-Hadassah Medical School, Jerusalem, Israel

2000

Hebrew University-Hadassah Medical School, 91120, Jerusalem, Israel

1999

Department of Ophthalmology, The Brown School of Public Health and Community Medicine, Hadassah University Hospital, Jerusalem, Israel.

1998

Hebrew University – Hadassah Medical School, Jerusalem, Israel

Department of Ophthalmology, Hadassah University Hospital, Jerusalem,

1997

Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel.

1996

Department of Ophthalmology, Hadassah University Hospital and Hebrew University-Hadassah Medical School, Jerusalem, Israel. PO Box 12000, Jerusalem 91120, Israel. Tel: (+ 972) 2–6776326; Fax: (+ 972) 2–6434434.

1995

The Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel.

1994

Departments of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel

1993

Department of Ophthalmology, The Brown School of Public Health and Community Medicine, Hadassah University Hospital, Jerusalem, Israel

1992

Department of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel.

1989

Department of Ophthalmology, University of California at San Diego

1987

Department of Ophthalmology, University of California at San Diego, San Diego, California

Prominent publications by Joseph Frucht‐Pery

KOL-Index: 11090 . PURPOSE: To report our results of 12 consecutive patients with conjunctival primary acquired melanosis (PAM) with atypia who were treated by topical Mitomycin C (MMC). DESIGN: Retrospective interventional consecutive case series. METHODS: Twelve patients with PAM with atypia in one of their eyes who were treated by topical chemotherapy with MMC were included in this case study. Eyes with ...
Known for Pam Atypia | Primary Acquired Melanosis | Topical Mitomycin | Visual Acuity
KOL-Index: 10979 . OBJECTIVE: The purpose of the study is to evaluate the efficacy and risks of topical mitomycin C (MMC) for conjunctival-corneal intraepithelial neoplasia (CCIN). DESIGN: The study design was a clinical case series of CCIN. PARTICIPANTS: Seventeen patients, 16 with biopsy-confirmed CCIN and 1 with invasive squamous cell carcinoma (SCC), were included in the study. INTERVENTION: Patients ...
Known for Corneal Intraepithelial | Topical Mitomycin Mmc | Antineoplastic Carcinoma | Mitomycin Treatment
KOL-Index: 10531 . PURPOSE: To evaluate the success rate of highly gas permeable scleral contact lenses (SCL) for visual rehabilitation after penetrating keratoplasty (PK), over a period of up to 9 years. METHODS: A total database of 31 consecutive patient fitted with SCL between January 2004 and December 2009 was retrospectively reviewed. Demographic data, etiology prior to lens fitting, visual outcomes, ...
Known for Visual Rehabilitation | Contact Lens | Penetrating Keratoplasty | Corneal Graft
KOL-Index: 10372 . PURPOSE: To evaluate the efficacy, safety, and predictability of hyperopic laser in situ keratomileusis (H-LASIK). SETTING: Departments of Ophthalmology, Hadassah University Hospital, Jerusalem, and Assaf Harofeh Medical Center, Zerifin, Israel. METHODS: This prospective noncomparative case series studied the results of H-LASIK in the first 92 consecutive eyes of 50 patients with up to ...
Known for Situ Keratomileusis | Hyperopic Laser | Moderate Hyperopia | Intended Correction
KOL-Index: 8577 . PURPOSE: To describe the incidence, characteristics, risk factors, and clinical outcome of limbal stem cell deficiency (LSCD) resulting from topical treatment with mitomycin C (MMC) for primary acquired melanosis (PAM) with atypia. DESIGN: Retrospective, observational case series. PARTICIPANTS: Patients with LSCD who had been managed with topical MMC for PAM with atypia at the Ocular ...
Known for Stem Cell | Patients Lscd | Topical Mitomycin | Pam Atypia
KOL-Index: 8544 . PURPOSE: To assess the corneal iontophoretic delivery of gentamicin by drug-loaded hydrogel probe, and to determine the resultant ocular disposition and elimination of the drug from the cornea and anterior chamber. METHODS: Corneal iontophoresis of gentamicin sulfate was studied in healthy white rabbits by using drug-loaded disposable hydroxyethyl methacrylate (HEMA) hydrogel disk probes ...
Known for Hydrogel Iontophoresis | Rabbit Eye | Iontophoretic Treatment | Aqueous Humor
KOL-Index: 8403 . A patient who had primary acquired melanosis with marked atypia shown on histological studies received topical 0.02% mitomycin C for 2 weeks and 0.04% mitomycin C for an additional 2 weeks. Conjunctival biopsy specimens were obtained to evaluate the efficacy of the treatment. After the first course of mitomycin C administration, some decrease of conjunctival pigmentation was seen, and ...
Known for Primary Acquired Melanosis | Topical Mitomycin | Conjunctival Pigmentation | 2 Weeks
KOL-Index: 8207 . BACKGROUND: Recent studies have shown that nerve growth factor (NGF) is produced by and can act on several immune-inflammatory cells. OBJECTIVES: The objective of this study was to study the effects of NGF on human peripheral blood eosinophils and assess whether these cells produce and store NGF. METHODS: Eosinophils were purified by negative immunoselection (magnetic cell sorting systems, ...
Known for Eosinophils Ngf | Nerve Growth Factor | Peripheral Blood | Eosinophil Peroxidase
KOL-Index: 8110 . PURPOSE: To evaluate dexamethasone penetration to the eye after a short transcorneal and transscleral iontophoresis using a drug loaded hydrogel assembled on a portable iontophoretic device. METHODS: Iontophoresis of dexamethasone phosphate was studied in healthy rabbits using drug loaded disposable HEMA hydrogel sponges and portable iontophoretic device. Corneal iontophoretic ...
Known for Transscleral Iontophoresis | Dexamethasone Phosphate | Drug Loaded | Portable Iontophoretic Device
KOL-Index: 8063 . BACKGROUND: Postoperative recurrence of pterygium occurs in many patients. The authors studied the recurrence rate of pterygium after administration of a single intraoperative dosage of topcial mitomycin C at the completion of pterygium excision. METHODS AND PATIENTS: Eighty-one patients underwent excision of the pterygium, leaving the sclera bare. The first 60 patients were randomized ...
Known for Intraoperative Application | Topical Mitomycin | Pterygium Surgery | Antineoplastic Chemotherapy
KOL-Index: 7975 . PURPOSE: Ocular hypertension is a potentially serious complication after penetrating keratoplasty (PKP). Our objective is to determine the risk factors, incidence, patient characteristics, response to pressure-lowering medical therapy, and graft outcome associated with elevation of intraocular pressure after PKP. METHODS: One hundred forty-six consecutive eyes that had PKP between June ...
Known for Ocular Hypertension | Keratoplasty Pkp Pkp | Preexisting Glaucoma | Pressure Iop
KOL-Index: 7971 . AIMS: To compare the proliferative activity of intraepithelial melanocytes in primary acquired melanosis (PAM) without atypia and PAM with atypia by immunohistochemical staining for the Ki-67 antigen and the proliferating cell nuclear antigen (PCNA). METHODS: Formalin fixed, paraffin embedded sections from 35 archival specimens of PAM without atypia (n = 19) and with atypia (n = 16) were ...
Known for Proliferative Activity | Primary Acquired Melanosis | Atypia Pam | Ki67 Antigen
KOL-Index: 7884 . PURPOSE: To compare the clinical outcome of pterygium surgery combining intraoperative mitomycin C (MMC) with a free conjunctival autograft, with three other methods of pterygium surgery, including intraoperative MMC alone, conjunctival autograft alone, and bare sclera without adjunctive treatment. DESIGN: Interventional, randomized and in part nonrandomized, prospective, comparative ...
Known for Conjunctival Autograft | Pterygium Surgery | 30 Patients | Intraoperative Mitomycin Mmc

Key People For Ocular Hypertension

Top KOLs in the world
#1
Harry A Quigley
optic nerve intraocular pressure experimental glaucoma
#2
Michael A Kass
ocular hypertension central corneal thickness visual field
#3
Robert Neal Weinreb
intraocular pressure visual field optic nerve
#4
Mae O Gordon
ocular hypertension central corneal thickness corneal scarring
#5
Eve J Higginbotham
ascorbic acid ocular hypertension trabecular meshwork
#6
Chris A Johnson
visual field automated perimetry ocular hypertension

Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel | Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel | Department of Ophthalmology, Cornea and Refractive Surgery Unit, Hadassah Medic